Marotta F, Safran P, Tajiri H, Princess G, Anzulovic H, Idéo G M, Rouge A, Seal M G, Idéo G
Hepatogastroenterology Dept., S. Giuseppe Hospital, Milano, Italy.
Hepatogastroenterology. 2001 Mar-Apr;48(38):511-7.
BACKGROUND/AIMS: It has been shown that alcohol impairs erythrocyte (red blood cell) membrane fluidity and lipid composition. The aim of this study was to test the effect of a novel acid-resistant antioxidant on the hemorrheology in alcoholics.
Thirty alcoholics (25 males, 5 females; mean age: 42 years; range: 31-54; 150 g ethanol/day for 3-5 years) were enrolled into the study. Patients were randomly and double-blindly allocated into 2 groups which were given, for a 2 week period, 18 g/day of Bionormalizer (obtained from biofermentation of carica papaya, pennisetum purpureum, sechium edule, Osato Res. Foundation, Gifu, Japan) dissolved in 5 mL of water at bedtime and 3 hours prior to examination. Placebo consisted of flavored sugar. Healthy teetotalers served as control. On the examination day, blood samples were taken for testing: routine tests, plasma glutathione, ascorbic acid, selenium, plasma lipid hydroperoxides and alpha-tocopherol. Erythrocytes were separated and tested for red blood cell malonyldialdehyde and glutathione content. The hemorheological studies were as follows: blood and plasma viscosity, whole blood filterability, red blood cell membrane fluidity by electron spin resonance, red blood cell aggregation index by photometric rheoscopy and red blood cell deformability by ektacytometry.
As compared to healthy controls, alcoholics on placebo treatment showed no change of plasma viscosity but a significantly higher red blood cell malonyldialdehyde, blood viscosity (P < 0.05) and lower plasma glutathione, whole blood filterability and red blood cell fluidity (P < 0.01). No relationship appeared between biochemical tests and red blood cell membrane fluidity. Bionormalizer group showed a significant recovery to control values of either blood viscosity and whole blood filterability (P < 0.01) and a partial, although significant, improvement of red blood cell membrane fluidity, red blood cell malonyldialdehyde and plasma glutathione (P < 0.05). As compared to healthy control, red blood cell aggregation decreased in alcoholics (P < 0.05) and was not affected by Bionormalizer. However, Bionormalizer significantly improved the reduced red blood cell deformability (P < 0.05 vs. alcoholics) and this parameter correlated with red blood cell malonyldialdehyde (r: 0.62. P < 0.05).
These preliminary data suggest that an effective antioxidant supplementation is able to improve the hemorrheology in alcoholics either by directly affecting the ethanol-related lipoperoxidation and xanthine oxidase system activation and/or by modifying red blood cell membrane characteristics.
背景/目的:已有研究表明,酒精会损害红细胞膜的流动性和脂质组成。本研究的目的是测试一种新型耐酸抗氧化剂对酗酒者血液流变学的影响。
30名酗酒者(25名男性,5名女性;平均年龄:42岁;范围:31 - 54岁;每天摄入150克乙醇,持续3 - 5年)被纳入研究。患者被随机双盲分为两组,在2周的时间里,一组在睡前和检查前3小时服用溶解于5毫升水中的18克/天的生物归一化剂(由番木瓜、紫狼尾草、佛手瓜生物发酵制得,日本岐阜大日本制药株式会社),另一组服用调味糖作为安慰剂。健康戒酒者作为对照。在检查当天,采集血样进行检测:常规检查、血浆谷胱甘肽、抗坏血酸、硒、血浆脂质过氧化物和α - 生育酚。分离红细胞并检测红细胞丙二醛和谷胱甘肽含量。血液流变学研究如下:血液和血浆粘度、全血过滤性、通过电子自旋共振检测红细胞膜流动性、通过光度流变学检测红细胞聚集指数以及通过激光衍射法检测红细胞变形性。
与健康对照组相比,服用安慰剂的酗酒者血浆粘度无变化,但红细胞丙二醛、血液粘度显著升高(P < 0.05),血浆谷胱甘肽、全血过滤性和红细胞流动性降低(P < 0.01)。生化检测与红细胞膜流动性之间未发现相关性。生物归一化剂组血液粘度和全血过滤性显著恢复至对照值(P < 0.01),红细胞膜流动性、红细胞丙二醛和血浆谷胱甘肽虽有部分但显著改善(P < 0.05)。与健康对照组相比,酗酒者的红细胞聚集减少(P < 0.05),且不受生物归一化剂影响。然而,生物归一化剂显著改善了降低的红细胞变形性(与酗酒者相比,P < 0.05),且该参数与红细胞丙二醛相关(r:0.62,P < 0.05)。
这些初步数据表明,有效的抗氧化剂补充能够通过直接影响与乙醇相关的脂质过氧化和黄嘌呤氧化酶系统激活和/或通过改变红细胞膜特性来改善酗酒者的血液流变学。